Filter
9
Featured
Language
Document type
Videos
4
Resource Platforms
2
Manuals
1
Training Material
1
App
1
Countries / Regions
Latin America and the Carribbean
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
4
Center for Disease Control and Prevention CDC
1
Kita, K.
1
Nagasaki University School of Tropical Medicine and Global Health
1
Pan American Health Organisation PAHO
1
World Health Organisation (WHO)
1
World Health Organisation WHO
1
Yamada, H.
1
Publication Years
Category
Clinical Guidelines
2
Public Health
1
Countries
1
Toolboxes
Recognizing neglected tropical diseseases through changes on the skin. App for Android and IOS, free of charge. The App is available in English and French, with plans to explore translations into other languages, such as Portuguese and Spanish, to better serve diverse communities. A patient's skin... more
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for... more
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Africa.
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti... more
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often asso... more
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, and throughout the reticuloendothelial system, respectively. The infection can range from a... more
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.

Webinar on Cutaneous Leishmaniasis and the summary of the proceedings

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often... more
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin. The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because of the treatment, even though cutaneous leishmania... more